Having previously observed a relationship between MR activation and expression of cMyc, Ccnd1, and Ptgs2 (Cox2)56, we compared expression of these genes in adenocarcinomas from CKO and control mice. The gene discussed is NR3C2; the disease is adenocarcinoma.